Strides Pharma Science Limited
STAR
Rank in Stocks
#8735
Strides Pharma Science Limited is a pharmaceutical company that focuses on the... Strides Pharma Science Limited is a pharmaceutical company that focuses on the development, production, and worldwide commercialization of medicinal products. Its extensive global footprint spans Africa, Australia, North America, Europe, Asia, India, and various other international markets. The company's operations are structured into two distinct segments: Pharmaceutical and Biopharmaceutical. It provides a diverse range of generic pharmaceuticals, available in multiple formats including tablets, hard and soft gelatin capsules, sachets, liquids, nasal sprays, powders, solids, ointments, and creams. Furthermore, Strides Pharma Science creates branded generic offerings for treating chronic ailments such as women's health issues, central nervous system disorders, cardiovascular conditions, diabetes, dermatological concerns, and probiotic support, marketed under brands like Renerve, Unibrol, Combiart, Duotab, and Vitafer. For institutional business, the company supplies drugs targeting infectious diseases, including anti-retrovirals, anti-malarials, anti-tuberculosis, and Hepatitis treatments. Incorporated in 1990, the company is headquartered in Bengaluru, India. It was formerly known as Strides Shasun Limited before adopting its current name in July 2018.
Share Price
$10.67
Last synced: 2026-11-09
Market Cap
$983.27M
Change (1 day)
0.81%
Change (1 year)
2.27%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Strides Pharma Science Limited (STAR)
Category
Healthcare
EPS for Strides Pharma Science Limited (STAR)
EPS as of September 2026 TTM: $0.70
According to Strides Pharma Science Limited's latest financial reports, its current EPS (TTM) is $0.70. At the end of 2025 the company had an EPS of $0.52, an increase over its 2024 EPS of $-0.16.
EPS history for Strides Pharma Science Limited from 2004 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.70 | 35.15% |
| 2025 | $0.52 | -425.13% |
| 2024 | $-0.16 | -47.01% |
| 2023 | $-0.30 | -55.75% |
| 2022 | $-0.68 | -274.10% |
| 2021 | $0.39 | 983.80% |
| 2020 | $0.04 | -57.43% |
| 2019 | $0.08 | -207.00% |
| 2018 | $-0.08 | -125.14% |
| 2017 | $0.31 | 74.11% |
| 2016 | $0.18 | 4,176.19% |
| 2015 | 0.00 | -100.28% |
| 2014 | $-1.48 | -156.52% |
| 2012 | $2.63 | 260.80% |
| 2011 | $0.73 | 24.63% |
| 2010 | $0.58 | 2.53% |
| 2009 | $0.57 | 2.72% |
| 2008 | $0.55 | -240.22% |
| 2007 | $-0.40 | -266.22% |
| 2006 | $0.24 | -20.13% |
| 2005 | $0.30 | 23.29% |
| 2004 | $0.24 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | 825.07% |
DE
|
|
| $6.08 | 764.77% |
DE
|
|
| $1.55 | 120.63% |
JP
|
|
| $3.66 | 420.77% |
CH
|
|
| $0.45 | -35.97% |
IL
|
Questions about Strides Pharma Science Limited's earnings per share (EPS)
What is Strides Pharma Science Limited's earnings per share (EPS)?
Strides Pharma Science Limited's earnings per share (EPS) over the last twelve months is $0.70, as of Sep 2026.
What was Strides Pharma Science Limited's earnings per share (EPS) in 2025?
In 2025, Strides Pharma Science Limited's earnings per share (EPS) was $0.52, compared with $-0.16 in 2024.
How has Strides Pharma Science Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Strides Pharma Science Limited's earnings per share (EPS) went from $0.04 to $0.52, an average growth of 67.03% a year.
How does Strides Pharma Science Limited's earnings per share (EPS) compare with similar companies?
Strides Pharma Science Limited's earnings per share (EPS) ($0.70) is higher than that of 1 of the 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.